Arnab De, an Indian scientist working at Columbia University in the US, claims to have found a new biological pathway that holds hope for cancer cure.
De also claims to have discovered a previously unknown biological pathway that is essential to fight off infections caused by bacteria and viruses. He says he has developed a transgenic animal model, an animal in which there has been a deliberate modification of the genome that could be used to study the role of A20 gene for cancer cure.
"I have created a transgenic mouse to study the action of A20 (gene) in living animals. "It will help to understand the mechanism by which A20 works in healthy individuals and patients," De, a postdoctoral scientist at Columbia University, told IANS over phone from the US.
He said that "A20 is a tumor-suppressor and this one gene is dysfunctional in a number of different cancers".
"For example, we find that patients of both B cell lymphoma and lung cancer have mutations in this gene, although at different places along the gene. We cloned stem cells having a single active amino acid mutation of A20. We then injected these bioengineered stem cells into blastocysts and subsequently generated transgenic knock-in animals from these stem cells.
"Previous understanding of A20 would have predicted the development of the various diseases in these animals. Surprisingly, these animals developed normally and had a healthy life. It is obvious to see why the work has important ramifications for cancer patients," said De.
He was involved in the two high-profile projects and has worked with internationally reputed Indian-American immunologist Sankar Ghosh.
De, who completed his PhD from Columbia University, is a cricket aficionado and has chosen to dedicate his thesis to Indian batting legend Sachin Tendulkar.
"Sachin Tendulkar is the greatest batsman of the post-war era and holds every record that we can imagine. I dedicate this thesis to Tendulkar for the way he has inspired Indian youth for the past 25 years."
Arnab has also helped in a drug-discovery at Indiana University where he worked with Richard DiMarchi, a professor.
(Jitendra Singh can be contacted at scribejks@gmail.com)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
